SCHEMBL20869899

SCHEMBL20869899

C[C@H](N)[C@H](NC(=O)OCc1ccccc1)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSL P07711 4/20 0.57
CTSS P25774 4/20 0.57
ATM Q13315 1/20 0.56
CTSB P07858 3/20 0.55
CTSK P43235 4/20 0.54
MEN1 O00255 1/20 0.53
LMNA P02545 1/20 0.53
KMT2A Q03164 1/20 0.53
CA2 P00918 2/20 0.52
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA9 Q16790 1/20 0.52
CTRB1 P17538 2/20 0.52
ELANE P08246 1/20 0.52
TRPM8 Q7Z2W7 1/20 0.51
ECE1 P42892 2/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20854293 1.00 CTSL (0.57) CTSLCTSSATMCTSBCTSK
SCHEMBL20854292 1.00 CTSL (0.57) CTSLCTSSATMCTSBCTSK
Hydrochloric Acid SCHEMBL5672176 0.99 CTSL (0.56) CTSLCTSSATMCTSBCTSK
Hydrochloric Acid SCHEMBL20854193 0.99 CTSL (0.56) CTSLCTSSATMCTSBCTSK
Hydrochloric Acid SCHEMBL20854290 0.99 CTSL (0.56) CTSLCTSSATMCTSBCTSK
Hydrochloric Acid SCHEMBL20876819 0.99 CTSL (0.56) CTSLCTSSATMCTSBCTSK
Formic Acid SCHEMBL28896984 0.95 CTSL (0.53) CTSLCTSSATMCTSBCTSK
Formic Acid SCHEMBL28896986 0.95 CTSL (0.53) CTSLCTSSATMCTSBCTSK
SCHEMBL21890679 0.90 TRPM8 (0.60) CTSLCTSSATMCTSBCTSK
Isopropylamine SCHEMBL10558459 0.90 CTSL (0.59) CTSLCTSSATMCTSBCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210009580-A1 AZTREONAM DERIVATIVES AND USES THEREOF ARIXA PHARMACEUTICALS, INC. 2021-01-14 US disclosed
US-10815228-B2 Aztreonam derivatives and uses thereof ARIXA PHARMACEUTICALS, INC. (US) 2020-10-27 US disclosed
US-20190211006-A1 AZTREONAM DERIVATIVES AND USES THEREOF ARIXA PHARMACEUTICALS, INC. 2019-07-11 US disclosed
US-10280161-B2 Aztreonam derivatives and uses thereof ARIXA PHARMACEUTICALS, INC. (US) 2019-05-07 US disclosed
WO-2019070595-A1 AZTREONAM DERIVATIVES AND USES THEREOF ARIXA PHARMACEUTICALS, INC. (US) 2019-04-11 WO disclosed
US-20190100516-A1 AZTREONAM DERIVATIVES AND USES THEREOF ARIXA PHARMACEUTICALS, INC. 2019-04-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10280161-B2 Aztreonam derivatives and uses thereof MGAM, ABCG2, SI CTSL 1068/4885CTSS 2631/4885ATM 697/4885
US-20190211006-A1 AZTREONAM DERIVATIVES AND USES THEREOF MGAM, ABCG2, SI CTSL 1068/4885CTSS 2631/4885ATM 697/4885
US-20190100516-A1 AZTREONAM DERIVATIVES AND USES THEREOF MGAM, ABCG2, SI CTSL 1068/4885CTSS 2631/4885ATM 697/4885
US-10815228-B2 Aztreonam derivatives and uses thereof MGAM, ABCG2, SI CTSL 1068/4885CTSS 2631/4885ATM 697/4885
US-20210009580-A1 AZTREONAM DERIVATIVES AND USES THEREOF MGAM, ABCG2, SI CTSL 1068/4885CTSS 2631/4885ATM 697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.